aripiprazole-TDS (AQS1301) / Corium, Aequus Pharma - LARVOL DELTA

AQS1301: “The CHMP agreed to the request by the applicant for an extension of clock-stop to respond to the list of outstanding issues adopted in March 2020 [Schizophrenia]” (EMEA) - CHMP Final Minutes of the meeting on 28-30 April 2020

European regulatory • Schizophrenia

AQS1301: “The Committee was reminded of the status of this application and its remaining outstanding issues [Schizophrenia]” (EMEA) - CHMP Final Minutes of the meeting on 23-26 March 2020: "The Committee adopted a list of outstanding issues with a specific timetable"

European regulatory • Schizophrenia